Efficacy and Safety Assessment of Niacinamide Cosmetic Preparation: a Randomized Controlled Trial
Launched by UNIVERSITY OF SPLIT, SCHOOL OF MEDICINE · Dec 18, 2023
Trial Information
Current as of August 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness and safety of a cosmetic product containing niacinamide, which is a form of vitamin B3 known for its moisturizing benefits. The trial specifically aims to see how well this product works for individuals with skin conditions like hyperpigmentation, dry skin, and eczema. Participants will be healthy volunteers who can provide written consent to join the study, as long as they do not have any skin diseases or recent skin damage, and haven’t used certain medications or been exposed to specific conditions before and during the trial.
If you choose to participate, you’ll be part of a controlled study where some people will receive the niacinamide treatment, while others will not, allowing researchers to compare the results. The trial is currently recruiting participants of all genders and ages. It's important to note that pregnant or breastfeeding women cannot take part, and anyone who has used certain skin treatments recently will be excluded. This trial is a great opportunity to contribute to research that could help improve skincare products for everyone!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • healthy volunteers who gave written informed consent
- Exclusion Criteria:
- • skin disease, skin damage on measurement sites, use of corticosteroids and immunomodulators a month prior to the inclusion and during the trial, non-adherence to the trial protocol, exposure to artificial UV radiation, pregnancy and lactation
About University Of Split, School Of Medicine
The University of Split, School of Medicine is a leading academic institution dedicated to advancing medical education, research, and clinical practice. Committed to fostering innovation and improving patient care, the School conducts rigorous clinical trials that explore cutting-edge therapies and interventions. With a focus on collaboration and multidisciplinary approaches, the institution aims to translate research findings into practical applications, enhancing healthcare outcomes both locally and globally. Through its robust infrastructure and expertise, the University of Split School of Medicine strives to contribute significantly to the medical field and the well-being of the community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Split, , Croatia
Patients applied
Trial Officials
Dario Leskur
Study Director
USSM
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported